Stocks to buy

When the U.S. first suffered the initial disruption from the novel coronavirus pandemic, many companies scrambled to find work-from-home solutions. Immediately, Slack Technologies (NYSE:WORK) quick rose to the forefront. Slack specializes in organizational communication platforms that efficiently sharing data among various parties. Following the crisis, such mechanisms became all the more critical, bolstering the bullish

Procter & Gamble (NYSE:PG) is one of the few companies that focuses intensely on free cash flow (FCF) productivity. This concentration has served shareholders in PG stock quite well over the past year — and it will continue to do so. Source: Jonathan Weiss / Shutterstock.com For example, the stock has risen 15% over the

Novavax (NASDAQ:NVAX) is a contender in the race to deliver a novel coronavirus vaccine and as such, NVAX stock is, at times, a turbulent name. Source: Ascannio/Shutterstock.com A year-to-date gain of nearly 2,600% as of Aug. 28 is undoubtedly eye-popping. So was a decline of 25% last week, a period including news that Novavax is

Semiconductor industry heavyweight Intel (NASDAQ:INTC) stock has not had a good 2020 so far. Year-to-date, INTC stock is down over 15%. Source: JHVEPhoto / Shutterstock.com Santa Clara, California-based Intel is also known as “Chipzilla.” Some of its products include microprocessors, chipsets, embedded processors, flash memory, systems management software and digital imaging products. Semiconductors are regarded

Biotech and pharmaceutical companies are seeing an unprecedented boom in 2020. The race for a novel coronavirus vaccine has lit a fuse under many stocks in that sector. Also seeing a boom this year are electric car stocks. Mohammad Niamat Elahee, a professor in the Department of International Business at Quinnipiac University, writes: “While electric

With another round of funding, Robinhood has seen its valuation surge to $11.2 billion. Its not surprising considering the fact that the company added 3 million new customer accounts at the beginning of fiscal year 2020. As markets continue to trade near all-time-highs, retail investor interest remains elevated. Capital preservation is one of the most

Long-term investors should buy Snap (NYSE:SNAP) stock, as the company’s second-quarter results show that it’s continuing to benefit from strong, positive trends. Moreover, the social media company should get a boost from a stronger post-pandemic advertising environment. Source: Ink Drop / Shutterstock.com Snap’s second quarter revenue increased 17% year-over-year to $454 million, versus analysts’ average

By now, you probably know Virgin Galactic (NYSE:SPCE) as that overly ambitious space company headed by Richard Branson. And since 2007, he claimed that the company is going to commercially fly people into outer-space. Yet, here we are in 2020; No such flights have happened, and SPCE stock investors are starting to get fed up. Source: Tun

The novel coronavirus has fundamentally altered the investing landscape. Many sectors that were already struggling, like energy and brick-and-mortar retail, have seen their slow declines turn into abject free fall. Other businesses, such as video gaming and work-from-home software companies, are booming. Many companies that initially plunged are now turning into huge rebound stocks. For

Recent data on Gilead’s (NASDAQ:GILD) treatment for the novel coronavirus, remdesivir, along with multiple indications that  demand for the drug is strong, have caused me to continue to be upbeat on GILD stock. Source: Casimiro PT / Shutterstock.com Further, a key supply deal involving remdesivir and an overreaction to negative news about another one of

Up nearly 150% this year, Square (NYSE:SQ) could be due for a pullback at some point soon. Investors should hope that scenario comes to pass because SQ stock is set up for long-term gains. Source: IgorGolovniov / Shutterstock.com The novel coronavirus pandemic is cementing Square’s status as one of the must-own fintech names. That’s impressive

Etsy (NASDAQ:ETSY) is a niche e-commerce website specializing in handmade and vintage goods. ETSY stock launched its initial public offering (IPO) back in 2015, initiating around $25 per share. Source: Shutterstock ETSY was initially a bust, with shares sliding into the single digits. But the company turned things around starting in 2018. Now the stay-at-home

Maryland-based vaccine maker Novavax (NASDAQ:NVAX) has been one of 2020’s high-flying stocks. Closing out 2019 at under $4, NVAX stock hit $178.51 on Aug. 10. That’s a whopping gain of nearly 4,400% in just eight months. Source: Ascannio/Shutterstock.com The reason for that remarkable performance was the novel coronavirus pandemic. More specifically, Novavax’s Covid-19 vaccine efforts.

Alibaba (NYSE:BABA) is at an all-time high. After middling around in the early summer, Alibaba stock broke out in early July and it hasn’t looked back. But at the time of this writing the stock is up over 11% since the e-commerce giant reported earnings on August 20. That has some investors wondering if Alibaba

German biotech firm, CureVac (NASDAQ:CVAC), has gained some major heat since making its debut in the public market less than two weeks ago. The company saw its shares nearly tripled in value on the first day of trading and CureVac stock rose from $16 per share to $44. Source: Shutterstock The need for a vaccine

Broadly speaking, U.S. equities are once again easily their foreign counterparts, but some of the best international stocks to consider hinge on reopening global economies and vanquishing the novel coronavirus. In fact, linking economic reopening to the best international stock ideas could be rewarding for investors because broader ex-US benchmarks are lagging this year. While

I’ll be among the first to acknowledge that taking a cruise right now seems like an awful and gross idea. But that doesn’t make me any less bullish about the long-term potential of Royal Caribbean (NYSE:RCL) stock. Source: Laszlo Halasi / Shutterstock.com In fact, I think RCL, even its dramatic rise over the last three

With shares trading sharply higher as of late, you may think you’ve missed the boat with Target (NYSE:TGT) stock. But even at around $140 per share, shares remain a solid buy. How so? For starters, the novel coronavirus remains a tailwind, not a headwind, for the retailer. Source: jejim / Shutterstock.com Sure, this has been

Throughout his presidency, Donald J. Trump has consistently waged an aggressive policy toward China. Later, this aggressiveness culminated in a trade war between the word’s top two economies. But with the novel coronavirus pandemic, the President has ratcheted up both his words and actions. Because of the unprecedented nature of this simmering feud, it will

As the race to identify and bring a novel coronavirus vaccine to market heats up, biotechnology-sector investors should appreciate that this is an international effort. In that light, a pivotal development in Europe for Novavax (NASDAQ:NVAX) should provide encouragement to NVAX stock holders. Source: Cryptographer / Shutterstock.com The company’s shareholders were undoubtedly in need of